Skip to main content
U.S. flag

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Find more clinical trials

Improving Well-Being for Older Adult Family Dementia Caregivers

Start: July 18, 2016
End: May 2023
Enrollment: 240

What Is This Study About?

This study will examine the effects of two interventions, the Mindfulness-Based Stress Reduction (MBSR) program and the Living Well program, on immune function, physical and emotional health, and well-being of older adults who care for a family member with dementia. MBSR is designed to teach skills for increasing relaxation and awareness, with special emphasis on movement, meditation, and breathing. The Living Well program includes group presentations and discussions on topics related to health and well-being in the context of dementia caregiving. Participants will be randomly assigned to either the MBSR program, the Living Well program, or a usual care group for eight weeks.

Do I Qualify To Participate in This Study?

Minimum Age: 55 Years

Maximum Age: N/A

Must have:

  • English speaking
  • Primary caregiver who provides unpaid daily in-person care for a family member or close friend with dementia who lives in the community
  • Moderate to high levels of perceived stress and/or caregiver burden
  • Stable medication use before and during trial

Must NOT have:

  • Person with dementia resides in a long-term care facility, such as a nursing home, without the caregiver
  • Major, uncorrected hearing or vision impairments
  • Cognitive deficits as defined by a Montreal Cognitive Assessment score of 23 or lower
  • Other neuropsychological deficits that could interfere with study participation
  • Current alcohol or substance use dependence
  • Psychotic disorders (current and lifetime), bipolar disorder, and current mood disorder with psychotic features
  • Completion of an MBSR program in the past
  • Allergy to eggs
  • History of Guillain-Barre syndrome
  • Immunodeficiency or receipt of immunosuppressive therapy
  • Recent major surgery
  • Active neoplastic disease

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: University of Rochester

Collaborator Sponsor

  • National Institute on Aging (NIA)

Source: ClinicalTrials.gov ID: NCT03881631

alzheimers.gov

An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health